Neurocrine Biosciences (NBIX) Gross Profit Growth (1y) (2018 - 2026)
Neurocrine Biosciences (NBIX) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 5.06% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 2.59% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -7.66% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -37.68% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 42.12% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 14.77% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -163.22% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -2.85% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -7.87% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 7,497.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.12% |
| Dec 31, 2025 | 27.41% |
| Sep 30, 2025 | 27.16% |
| Jun 30, 2025 | 16.39% |
| Mar 31, 2025 | 10.95% |
| Dec 31, 2024 | 22.04% |
| Sep 30, 2024 | 25.94% |
| Jun 30, 2024 | 31.69% |
| Mar 31, 2024 | 23.28% |
| Dec 31, 2023 | 25.33% |
| Sep 30, 2023 | 27.71% |
| Jun 30, 2023 | 2,802.63% |
| Mar 31, 2023 | 34.61% |
| Dec 31, 2022 | 31.31% |
| Sep 30, 2022 | 30.84% |
| Jun 30, 2022 | -94.68% |
| Mar 31, 2022 | 30.94% |
| Dec 31, 2021 | 25.67% |
| Sep 30, 2021 | 14.07% |
| Jun 30, 2021 | -4.73% |